Trends, Costs, and Complications of Anterior Cervical Discectomy and Fusion With and Without Bone Morphogenetic Protein in the United States Medicare Population

STUDY DESIGN: Retrospective database review. OBJECTIVES: After the Food and Drug Administration approved bone morphogenetic protein–2 (BMP) in 2002, BMP was used off-label in the cervical spine to increase bone growth and bony fusion. Since then, concerns have been raised regarding complication rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lord, Elizabeth L., Cohen, Jeremiah R., Buser, Zorica, Meisel, Hans-Joerg, Brodke, Darrel S., Yoon, S. Tim, Youssef, Jim A., Wang, Jeffrey C., Park, Jong-Beom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624371/
https://www.ncbi.nlm.nih.gov/pubmed/28989837
http://dx.doi.org/10.1177/2192568217699207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624371/
https://www.ncbi.nlm.nih.gov/pubmed/28989837
http://dx.doi.org/10.1177/2192568217699207

Ejemplares similares